[8] Kalra S, et al
Exploring how metabolic checkpoints, such as AMPK or mTOR, influence TRAIL-R-induced apoptosis could pave the way for innovative metabolic-immunotherapeutic approaches
After GLP-1s, lifestyle is no longer a supporting player, Zilbermint said
Studies in knock-out mice confirms the significant potential for novel triple-acting hybrid peptides as therapeutic options for obesity (128)
Discuss with your endocrinologist If you have a seizure history: high-dose L-carnitine has been associated with increased seizure frequency in susceptible individuals in rare reports A 2013 Cleveland Clinic study raised concern about gut bacteria converting L-carnitine to TMAO (trimethylamine N-oxide), a compound associated with cardiovascular risk
This blog discusses GLP-1 analogues, like semaglutide, Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide, which are groundbreaking medications for managing weight loss and type 2 diabetes